Dupixent (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color…
GRVT Introduces Retail Price Improvement Orders, Bringing Proven TradFi Execution Benefits Onchain
SINGAPORE, June 4, 2025 /PRNewswire/ -- GRVT, the world's first licensed onchain…
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to…
Suhana Spices Elevates Manufacturing Excellence with Altizon’s Digital Factory (DFX) Platform
PUNE, India, April 28, 2025 /PRNewswire/ -- Pravin Masalewale (Suhana), has successfully…
THE Asia University Ranking 2025 Declared – KIIT Rises to 184th Position in Asia; 8th in India
BHUBANESWAR, India, April 25, 2025 /PRNewswire/ -- Like every year, the Times…
FINRA Announces New FINRA Forward Initiatives to Support Members, Markets and Investors
WASHINGTON--(BUSINESS WIRE)--FINRA announced today the launch of FINRA Forward, a series of…
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates
March 17, 2025 08:00 ET | Source: CervoMed Inc. -Reported positive 16-week…
Bybit Surpasses Market Leaders in Spot Liquidity with Innovative RPI Order Launch
DUBAI, UAE, March 6, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader…
Golden Gate Global Celebrates Significant Improvement in I-829 Petition Processing Timelines
SAN FRANCISCO, Feb. 20, 2025 /PRNewswire/ -- Golden Gate Global (GGG), a…